Invention Grant
- Patent Title: Sulfonamides for the modulation of PKM2
- Patent Title (中): 用于调节PKM2的磺酰胺
-
Application No.: US13281929Application Date: 2011-10-26
-
Publication No.: US08692001B2Publication Date: 2014-04-08
- Inventor: Oren M. Becker , Alina Shitrit , Nili Schutz , Efrat Ben-Zeev , Avihai Yacovan , Rachel Ozeri , Tzofit Kehat , Sima Mirilashvili , Alex Aizikovich , Daniel Sherman , Vered Behar , Osnat Kashtan
- Applicant: Oren M. Becker , Alina Shitrit , Nili Schutz , Efrat Ben-Zeev , Avihai Yacovan , Rachel Ozeri , Tzofit Kehat , Sima Mirilashvili , Alex Aizikovich , Daniel Sherman , Vered Behar , Osnat Kashtan
- Applicant Address: IL Rehovot
- Assignee: Dynamix Pharmaceuticals Ltd.
- Current Assignee: Dynamix Pharmaceuticals Ltd.
- Current Assignee Address: IL Rehovot
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Main IPC: C07D405/02
- IPC: C07D405/02 ; A61K31/405
Abstract:
The invention relates to sulfonamide compounds and methods for activating PKM2. The compounds and methods are useful in treating or preventing a disease or disorder selected from cancer, cell proliferative disorder, inflammatory disorder, metabolic disorder, and immune system disorder.
Public/Granted literature
- US20120108631A1 Sulfonamides for the Modulation of PKM2 Public/Granted day:2012-05-03
Information query
